Biogen Inc. (ETR:IDP)
121.35
-1.70 (-1.38%)
Sep 19, 2025, 5:35 PM CET
Biogen Revenue
Biogen had revenue of $2.65B USD in the quarter ending June 30, 2025, with 7.33% growth. This brings the company's revenue in the last twelve months to $10.00B, up 3.36% year-over-year. In the year 2024, Biogen had annual revenue of $9.68B, down -1.62%.
Revenue (ttm)
$10.00B
Revenue Growth
+3.36%
P/S Ratio
2.09
Revenue / Employee
$1.31M
Employees
7,605
Market Cap
17.79B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.68B | -159.70M | -1.62% |
Dec 31, 2023 | 9.84B | -337.80M | -3.32% |
Dec 31, 2022 | 10.17B | -808.30M | -7.36% |
Dec 31, 2021 | 10.98B | -2.46B | -18.32% |
Dec 31, 2020 | 13.44B | -933.30M | -6.49% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Sartorius Aktiengesellschaft | 3.47B |
Fresenius Medical Care AG | 19.52B |
Fielmann Group AG | 2.40B |
Carl Zeiss Meditec AG | 2.18B |
Biogen News
- 2 days ago - A Look Into Biogen Inc's Price Over Earnings - Benzinga
- 2 days ago - Biogen (BIIB) to Acquire Alcyone Therapeutics for $85M - GuruFocus
- 2 days ago - December 19th Options Now Available For Biogen (BIIB) - Nasdaq
- 2 days ago - Biogen (BIIB) to Acquire Alcyone Therapeutics for Innovative Drug Delivery System - GuruFocus
- 2 days ago - Biogen to buy Massachusetts-based Alcyone Therapeutics - Seeking Alpha
- 2 days ago - Biogen To Acquire Alcyone Therapeutics - Nasdaq
- 2 days ago - Biogen to Acquire Alcyone Therapeutics, Expanding Drug Delivery Solution Portfolio for Key Product and Pipeline Candidates - GlobeNewsWire
- 3 days ago - Biogen (BIIB) Gains EU Approval for Post-Partum Depression Treatment - GuruFocus